Screening for lung cancer: The guidelines Journal Article


Authors: Bach, P. B.; Niewoehner, D. E.; Black, W. C.
Article Title: Screening for lung cancer: The guidelines
Abstract: Although virtually all individuals with advanced lung cancer succumb to the disease, a substantial portion of individuals diagnosed at an earlier stage can be cured. This dichotomy has provoked interest in lung cancer screening. To date, randomized controlled trials of chest x-ray and sputum cytology have failed to demonstrate that screening with either modality decreases lung cancer mortality; neither of these technologies can be recommended. Early studies of lung cancer screening with low-dose CT (LDCT) appear promising; however, only data from observational studies are available. We recommend that individuals should only be screened with LDCT in the context of well-designed clinical trials.
Keywords: cancer surgery; clinical trial; review; cancer risk; cancer diagnosis; diagnostic accuracy; clinical practice; evidence-based medicine; diagnostic procedure; computer assisted tomography; lung neoplasms; cancer screening; lung cancer; mass screening; tomography, x-ray computed; practice guideline; cancer mortality; radiography, thoracic; diagnostic value; randomized controlled trials; early diagnosis; thorax radiography; sputum cytodiagnosis; sputum; humans; human; male; female; priority journal; mass chest x-ray
Journal Title: Chest
Volume: 123
Issue: 1 Suppl.
ISSN: 0012-3692
Publisher: American College of Chest Physicians  
Date Published: 2003-01-01
Start Page: 83S
End Page: 88S
Language: English
PUBMED: 12527567
PROVIDER: scopus
DOI: 10.1378/chest.123.1_suppl.83S
DOI/URL:
Notes: Export Date: 25 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Peter Bach
    255 Bach